Skip to main content

Hypoxemia clinical trials at University of California Health

2 research studies open to eligible people

Showing trials for
  • Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

    open to eligible people ages 18 years and up

    This study seeks to define the ultrasound profile of patients with COVID-19, and document the progression of these ultrasound findings to develop prognostication and clinical decision instruments that can help guide management of patient with COVID-19. Primary aims include the development of ARDS, refractory hypoxemia, acute cardiac injury, pulmonary embolism, pneumothorax or death. Secondary aims include potential change in CT and plain film utilization given the use of POCUS, as well as emergency department and inpatient LOS (length of stay).

    at UCLA

  • Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation

    open to eligible people ages 18 years and up

    This is a prospective observational study designed to quantify and understand errors in pulse oximetry in hospitalized patients in relation to their skin pigmentation. It is driven by three recent retrospective studies showing missed diagnosis of hypoxemia in patients across a spectrum of skin pigmentation, defined as blood SaO2 <90% when their pulse oximeter reads 92% or greater.

    at UCSF

Our lead scientists for Hypoxemia research studies include .

Last updated: